Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 101

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Persistent Liver Biochemistry Abnormalities Are More Common in Older Patients and those With Cholestatic Drug Induced Liver Injury

Fontana, Robert J, Hayashi, Paul H, Barnhart, Huiman, Kleiner, David E, Reddy, Rajender K, Chalasani, Naga, Lee, William M, Stolz, Andrew, Phillips, Thomas, Serrano, Jose, Watkins, Paul B · 2015 · American Journal of Gastroenterology

Abstract

OBJECTIVES: The long-term outcomes of patients with drug induced liver injury (DILI) are not well described. The aim of this study was to determine the frequency and severity of persistent liver biochemistry abnormalities in DILI patients followed over 2 years. METHODS: Subjects with evidence of liver injury at 6 months after DILI onset were offered a month 12 and 24 study visit. RESULTS: Amongst the 99 patients with definite, probable, or very likely DILI and available laboratory data at 12 months after DILI onset, 74 (75%) had persistent liver injury (persisters) defined as a serum aspartate aminotransferase (AST) or alanine aminotransferase (ALT) >1.5 × upper limit of normal (ULN) or an alkaline phosphatase >ULN, while 25 (25%) had resolved liver injury (resolvers). On multivariate analysis, month 12 persisters were significantly older (52.6 vs. 43.7 years, P=0.01) and more likely to have a cholestatic lab profile at DILI onset (54 vs. 20%, P<0.01) than resolvers. The month 12 persisters also had significantly poorer SF-36 physical summary scores at DILI onset and throughout follow-up compared with the resolvers (P<0.01). Amongst the 17 subjects with a liver biopsy obtained at a median of 387 days after DILI onset, 9 had chronic cholestasis, 3 had steatohepatitis, and 3 had chronic hepatitis. CONCLUSIONS: In all, 75% of subjects with liver injury at 6 months after DILI onset have laboratory evidence of persistent liver injury during prolonged follow-up. Higher serum alkaline phosphatase levels at presentation and older patient age were independent predictors of persistent liver injury. Subjects with persistent liver injury at 12 months after DILI onset should be carefully monitored and assessed for liver disease progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ajg.2015.283

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 25

  1. Fontana, 2014, Idiosyncratic drug induced liver injury is associated with substantial morbidity and mortality within 6 months from onset., Gastroenterology, 147, 96, 10.1053/j.gastro.2014.03.045 · DOI · Paper page
  2. Chalasani, 2008, Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States., Gastroenterology, 135, 1924, 10.1053/j.gastro.2008.09.011 · DOI · Paper page
  3. Aithal, 1999, The natural history of histologically proved drug-induced liver disease., Gut, 44, 731, 10.1136/gut.44.5.731 · DOI · Paper page
  4. Bjornsson, 2009, The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice., J Hepatol, 50, 511, 10.1016/j.jhep.2008.10.021 · DOI · Paper page
  5. Bjornosson, 2007, Long-term follow-up of patients with mild to moderate drug-induced liver injury., Aliment Pharmacol Ther, 26, 79, 10.1111/j.1365-2036.2007.03355.x · DOI
  6. Fontana, 2009, Drug-induced liver injury network (DILIN) prospective study: rationale, design and conduct., Drug Saf, 32, 55, 10.2165/00002018-200932010-00005 · DOI · Paper page
  7. Rockey, 2010, Rochon J et al. for the US DILIN. Causality assessment in drug induced liver injury using a structured expert opinion process: comparison to RUCAM., Hepatology, 51, 2117, 10.1002/hep.23577 · DOI · Paper page
  8. Ware, 1999, Health-related quality of life in chronic hepatitis C: impact of disease and treatment response., Hepatology, 30, 264, 10.1002/hep.510300203 · DOI · Paper page
  9. Kleiner, 2014, Hepatic histological findings in suspected drug-Induced liver injury: systematic evaluation and clinical associations., Hepatology, 59, 661, 10.1002/hep.26709 · DOI · Paper page
  10. Williams, 2011, Prevalence of non-alcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study., Gastroenterology, 140, 124, 10.1053/j.gastro.2010.09.038 · DOI · Paper page
  11. Browning, 2004, Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity., Hepatology, 40, 1387, 10.1002/hep.20466 · DOI · Paper page
  12. Fontana, 2014, 2-year outcomes in initial survivors with acute liver failure: results from a prospective, multicenter study., Liver Int, 35, 370, 10.1111/liv.12632 · DOI
  13. Wiese, 2000, Low frequency of cirrhosis in a hepatitis C (genotype 1b) single source outbreak in Germany: a 20 year multicenter study., Hepatology, 32, 91, 10.1053/jhep.2000.8169 · DOI · Paper page
  14. Seeff, 2001, Long-term morbidity and mortality of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood institute Collaborative Study., Hepatology, 33, 455, 10.1053/jhep.2001.21905 · DOI · Paper page
  15. Feng, 2006, Characteristics associated with liver graft failure: the concept of a donor risk index., Am J Transplant, 6, 783, 10.1111/j.1600-6143.2006.01242.x · DOI · Paper page
  16. Yamasahiki, 2012, Outcomes after living donor liver transplantation for acute liver failure in Japan: results of a nationwide survey., Liver Transpl, 18, 1069, 10.1002/lt.23469 · DOI
  17. Fontana, 2013, Aging promotes the development of diet induced murine steatohepatitis but not steatosis., Hepatology, 57, 995, 10.1002/hep.26099 · DOI
  18. Levy, 2003, Drug-induced cholestasis., Clin Liv Dis, 7, 311, 10.1016/S1089-3261(03)00032-1 · DOI
  19. Mandapoor, 1994, Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis., Hepatology, 20, 1437, 10.1002/hep.1840200610 · DOI
  20. Davies, 1994, Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis., J Hepatol, 20, 112, 10.1016/S0168-8278(05)80476-3 · DOI
  21. Saxena, 2002, Destruction of canals of hering in primary biliary cirrhosis., Hum Pathol, 33, 983, 10.1053/hupa.2002.128060 · DOI
  22. Khan, 2013, Keratin 19 demonstration of canal of Hering loss in primary biliary cirrhosis: minimal change PBC?, Hepatology, 57, 700, 10.1002/hep.26020 · DOI
  23. Bedossa, 2003, Sampling variability of liver fibrosis in chronic hepatitis C., Hepatology, 38, 1449, 10.1053/jhep.2003.09022 · DOI · Paper page
  24. Bjornsson, 2010, Drug-induced autoimmune hepatitis: clinical characteristics and prognosis., Hepatology, 51, 2040, 10.1002/hep.23588 · DOI · Paper page
  25. Czaja, 2011, Drug-induced autoimmune-like hepatitis., Dig Dis Sci, 56, 958, 10.1007/s10620-011-1611-4 · DOI · Paper page

Cited by

See all 101

Metadata

Authors
Fontana, R. J., Hayashi, P. H., Barnhart, H., Kleiner, D. E., Reddy, R. K., Chalasani, N., Lee, W. M., Stolz, A., Phillips, T., Serrano, J., & Watkins, P. B.
Venue
American Journal of Gastroenterology
Published
2015-10
Volume
110
Issue
10
Pages
1450-1459
ISSN
0002-9270
Cited by
101
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.